ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

iksnamyzs (75.48) Submitted: 10/9/2006 3:17:54 PM : Start Price: $8.69 ISIS Score: +8.74

play based on new product

oman33 (58.43) Submitted: 10/6/2006 11:36:50 PM : Start Price: $8.00 ISIS Score: +18.40

potential killer product commercialized; early adopters enthusiastic. if approved for diagnostic use, will revolutionize typical microbiology lab. moreover, drug pipeline attractive.

schmosly (37.42) Submitted: 10/3/2006 5:55:43 PM : Start Price: $7.31 ISIS Score: +28.85

Has fantastic technoly and owns IBIS subsiduary which is just started sellig and has orders for a great new invention.Many more good stuff coming out of these two companies.

stanhutchings (< 20) Submitted: 8/26/2006 12:36:20 AM : Start Price: $7.20 ISIS Score: +27.37

boomers will need their products

mansloth (97.26) Submitted: 8/21/2006 1:23:53 AM : Start Price: $6.95 ISIS Score: -32.59

I've looked at this company a couple of times and always get a bad feeling. I've never shorted any business before, but you gotta start somewhere. I'll start with ISIS because:

their technology is antiquated

they are basically a one-trick pony

I don't think their pipeline is very impressive.

I get a very icky feeling from management.

Maybe they will do well, but I think the recent hype of their cholesterol drug is fog. I think this company is on its way down and out.